98 related articles for article (PubMed ID: 27012115)
21. The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia.
Yesilbursa D; Serdar A; Saltan Y; Serdar Z; Heper Y; Guclu S; Cordan J
Kardiol Pol; 2005 Jun; 62(6):526-30. PubMed ID: 16123850
[TBL] [Abstract][Full Text] [Related]
22. Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
Harangi M; Seres I; Magyar MT; Csipo I; Sipka S; Valikovics A; Csiba L; Bereczki D; Paragh G
Cerebrovasc Dis; 2008; 25(1-2):122-8. PubMed ID: 18073465
[TBL] [Abstract][Full Text] [Related]
23. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
[TBL] [Abstract][Full Text] [Related]
24. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.
Manfredini V; Biancini GB; Vanzin CS; Dal Vesco AM; Cipriani F; Biasi L; Treméa R; Deon M; Peralba Mdo C; Wajner M; Vargas CR
Cell Biochem Funct; 2010 Jul; 28(5):360-6. PubMed ID: 20589733
[TBL] [Abstract][Full Text] [Related]
26. Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.
Gupta N; Binu KB; Singh S; Maturu NV; Sharma YP; Bhansali A; Gill KD
Gene; 2012 Apr; 498(1):13-9. PubMed ID: 22333293
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population.
Sauriasari R; Sakano N; Wang DH; Takaki J; Takemoto K; Wang B; Sugiyama H; Sato Y; Takigawa T; Takahashi N; Kanbara S; Hitomi Y; Nakamura H; Ogino K
Hypertens Res; 2010 Nov; 33(11):1129-36. PubMed ID: 20703235
[TBL] [Abstract][Full Text] [Related]
28. Effects of simvastatin on pro-inflammatory cytokines in patients with hypercholesterolemia.
Zubelewicz-Szkodzińska B; Szkodziński J; Danikiewicz A; Romanowski W; Błazelonis A; Muc-Wierzgon M; Pietka-Rzycka A; Muryn Z
Kardiol Pol; 2003 Dec; 59(12):465-74. PubMed ID: 14724693
[TBL] [Abstract][Full Text] [Related]
29. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging.
Acampa W; Di Taranto MD; Morgante A; Salvatore B; Evangelista L; Ricci F; Costanzo P; de Sisto E; Filardi PP; Petretta M; Fortunato G; Cuocolo A
Scand J Clin Lab Invest; 2011 May; 71(3):179-84. PubMed ID: 21231776
[TBL] [Abstract][Full Text] [Related]
31. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
32. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
33. Serum paraoxonase 1 activity in women with metabolic syndrome.
Yilmaz H; Sayar N; Yilmaz M; Gurkan U; Sesal C; Tosu R; Cakmak N; Erer B; Oz D; Ciloglu F; Bolca O
Kardiol Pol; 2010 Nov; 68(11):1219-24. PubMed ID: 21108196
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
35. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
[TBL] [Abstract][Full Text] [Related]
36. Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study.
Rontu R; Karhunen PJ; Ilveskoski E; Mikkelsson J; Kajander O; Perola M; Penttilä A; Koivisto AM; Lehtimäki T
Atherosclerosis; 2003 Nov; 171(1):31-7. PubMed ID: 14642403
[TBL] [Abstract][Full Text] [Related]
37. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
[TBL] [Abstract][Full Text] [Related]
38. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
39. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
